Back
Day Range
$5.45
$5.73
52-Week Range
$3.21
$8.40
Volume
2,413,088
50D / 200D Avg
$6.82
/
$5.67
Prev Close
$5.35
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -22.5 | 0.2 |
| P/B | 8.3 | 3.0 |
| ROE % | -36.2 | 3.6 |
| Net Margin % | -15.1 | 3.8 |
| Rev Growth 5Y % | 152.0 | 10.0 |
| D/E | 1.3 | 0.2 |
Analyst Price Target
Hold
$17.00
+201.4%
Low: $15.00
High: $19.00
Forward P/E
7050.00
Forward EPS
$0.00
EPS Growth (est.)
+0.0%
Est. Revenue
550.07M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$2.18
$2.06 – $2.28
|
1.40B | 5 |
| FY2029 |
$1.78
$1.68 – $1.86
|
1.24B | 2 |
| FY2028 |
$1.18
$0.89 – $1.63
|
979.18M | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-19 | $0.01 | $0.02 | +53.8% |
| 2025-10-30 | -$0.06 | $0.00 | +93.3% |
| 2025-08-04 | -$0.13 | -$0.08 | +38.5% |
| 2025-05-01 | -$0.10 | -$0.17 | -70.0% |
| 2025-02-20 | $0.02 | $0.02 | 0.0% |
| 2024-10-31 | -$0.05 | $0.00 | +93.1% |
| 2024-08-01 | -$0.10 | -$0.07 | +30.0% |
| 2024-05-02 | -$0.13 | -$0.11 | +15.4% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 152.02% annually over 5 years — strong growth
Negative free cash flow of -43.98M
Revenue growth is decelerating — 1Y growth trails 5Y average by 129.93%
Capital efficient — spends only 0.37% of revenue on capex
Growth
Revenue Growth (5Y)
152.02%
Revenue (1Y)22.09%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-36.21%
ROIC-8.12%
Net Margin-15.12%
Op. Margin-10.06%
Safety
Debt / Equity
1.27
Current Ratio4.31
Interest Coverage-1.44
Valuation
P/E Ratio
-22.45
Forward P/E7050.00
P/B Ratio8.29
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 22.09% | Revenue Growth (3Y) | 80.91% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 152.02% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 407.32M | Net Income (TTM) | -61.60M |
| ROE | -36.21% | ROA | -12.28% |
| Gross Margin | 90.29% | Operating Margin | -10.06% |
| Net Margin | -15.12% | Free Cash Flow (TTM) | -43.98M |
| ROIC | -8.12% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.27 | Current Ratio | 4.31 |
| Interest Coverage | -1.44 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -22.45 | Forward P/E | 7050.00 |
| P/B Ratio | 8.29 | P/S Ratio | 3.40 |
| PEG Ratio | -0.43 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 2.51 | Fwd Earnings Yield | 0.01% |
| FCF Yield | -3.18% | ||
| Market Cap | 1.38B | Enterprise Value | 1.53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 407.32M | 333.62M | 124.46M | 52.16M | 10.10M |
| Net Income | -61.60M | -39.14M | -66.07M | -67.21M | -158.17M |
| EPS (Diluted) | -0.26 | -0.17 | -0.30 | -0.42 | -1.52 |
| Gross Profit | 367.78M | 283.06M | 106.66M | 48.04M | 9.10M |
| Operating Income | -40.98M | -27.95M | -63.28M | -63.76M | -154.35M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 501.60M | 435.75M | 297.58M | 190.07M | 149.91M |
| Total Liabilities | 334.66M | 262.47M | 130.76M | 91.74M | 67.30M |
| Shareholders' Equity | 166.95M | 173.29M | 166.82M | 98.33M | 82.62M |
| Total Debt | 211.60M | 153.44M | 55.98M | 36.46M | 45.50M |
| Cash & Equivalents | 68.00M | 64.93M | 21.47M | 96.14M | 72.43M |
| Current Assets | 382.32M | 356.45M | 246.11M | 153.60M | 133.65M |
| Current Liabilities | 88.61M | 77.83M | 50.39M | 65.60M | 52.82M |